| Literature DB >> 35685091 |
Zixuan Wang1,2, Baosheng Li1, Qing Cai1, Xiaoyu Li1, Zhaoyi Yin1, Birong Li1, Zhen Li1, Weiyan Meng1.
Abstract
In recent years, dental implantation has become the preferred protocol for restoring dentition defects. Being the direct contact between implant and bone interface, osseointegration is the basis for implant exerting physiological functions. Nevertheless, biological complications such as insufficient bone volume, poor osseointegration, and postoperative infection can lead to implant failure. Emerging antibacterial-osteogenic multifunctional implant surfaces were designed to make up for these shortcomings both during the stage of forming osseointegration and in the long term of supporting the superstructure. In this mini-review, we summarized the recent antibacterial-osteogenic modifications of the dental implant surface. The effects of these modifications on biological performance like soft tissue integration, bone osteogenesis, and immune response were discussed. In addition, the clinical findings and prospects of emerging antibacterial-osteogenic implant materials were also discussed.Entities:
Keywords: antibacterial; dental implant; immunity; osseointegration; osteogenesis; soft tissue integration; surface modification
Year: 2022 PMID: 35685091 PMCID: PMC9171039 DOI: 10.3389/fbioe.2022.921338
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
Antibacterial-osteogenic strategies of dental implant surface based on coating elements.
| Coating classification | Material composition | Bacterial Strains | Osteogenesis | References |
|---|---|---|---|---|
| Biomacromolecular Coating | Vitamin E Phosphate |
|
|
|
| TA/8DSS/PEG |
| BMSCs; promoting biomineralization and osseointegration |
| |
|
| ||||
| TA/HA/lysozyme |
| MC3T3-E1; promoting osteoblast mineralization and gene expression and ALP activity |
| |
|
| ||||
| HA/HBD-3/BMP-2 |
| hBMSC; promoting adhesion, proliferation, and osteogenic differentiation |
| |
|
| ||||
| PDA/nZnO/CS/nHA |
| MC3T3-E1; promoting osteogenic differentiation and ALP expression |
| |
|
| ||||
| Polymer Coating | Ti-RP/PCP/RSNO |
| MC3T3-E1; upregulating the expression of ALP, Opn and Ocn |
|
| SP@MX-TOB/GelMA |
| MC3T3-E1; improving the proliferation and diffusion of osteoblasts and the mineralization of calcium matrix |
| |
|
| ||||
| SPEEK@SA(CGA)@BFP |
| MC3T3; improving cell adhesion and proliferation and osteogenic differentiation |
| |
|
| ||||
| Ti-Br/PEG/RGD |
| MC3T3; promoting adhesion and proliferation of osteoblasts |
| |
| TiO2 Nanotube Coating | TNT/GelMA/PMAA-Cl/BMP-2 |
| Osteoblasts; promoting cell adhesion, proliferation and differentiation |
|
|
| ||||
| TNT/BMP2/(Chi/SL/Chi/Gel) 4 |
| Osteoblasts; improving cell viability, ALP activity, mineralization capacity and osteogenic gene expression |
| |
|
| ||||
| TNT/BMP2/LBLg |
| Osteoblasts; promoting differentiation of osteoblasts |
| |
|
| ||||
| TNT/Au NPs/Pt NPs |
| hMSCs; enhancing osteogenic function |
| |
| Metal Ion/Nanoparticle Coating | Cu/Hier/Ti |
| Macrophages; creating a favorable inflammatory micro-environment for SaOS-2 cells, promoting osseointegration |
|
| AH-Sr-AgNPs |
| Macrophages; promoting macrophage polarization and differentiation of pro-osteoblasts |
| |
| PLGA/Ag/Fe3O4 |
| Osteoblasts; promoting osteoblast proliferation |
| |
| nAg/µCuO/PDA/SF |
| Ad-MSC; enhancing osteogenic differentiation |
| |
|
|
ADA-Gen, alginate dialdehyde-gentamicin; A.naeslundii, Actinomyces naeslundii; BFP, grafted peptide; BMP-2, Bone morphogenetic protein-2; CGA, chlorogenic acid; CS/Chi, chitosan; Cu-Hier-Ti, Cu-containing micro/nano-topographical bio-ceramic; E.coli, Escherichia coli; GelMA, gelatin methacrylate; HA, hydroxyapatite; HBD-3, human β-defensin 3; LBLg, LBL/ADA-Gen; MRSA, Methicillin resistant Staphylococcus aureus; MX, MXene; nAg, silver nanoparticles; nHA, nanocrystal hydroxyapatite; nZnO, ZnO nanoparticles; PCP, PVA/CS/PDA; PDA, polydopamine; PEG, polyethylene glycol; PLGA, poly(lactic-co-glycolic acid; PMAA-Cl, N-Cl modification poly (N,N′-methylene bis(acrylamide)); PVA, polyvinyl alcohol; RGD, arginine-glycine-aspartic; RSNO, a NO, donor of S-nitrosuccinic acid; SA, sodium alginate; S.aureus, Staphylococcus aureus; SL, sodium hyaluronate-lauric acid; S.mutans, Streptococcus mutans; SPEEK/SP, sulfonated polyetheretheretherketone; TA, tannic acid; TNT, TiO2 nanotubes; TOB, tobramycin; µCuO, copper oxide microspheres; 8DSS, 8 repeating units of aspartate-serine-serine.
FIGURE 1Bone physiology for biomimicry of candidate biomaterials for bone-tissue engineering. Reproduced with permission from Koons et al. (2020).